- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/48 - Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
Patent holdings for IPC class C07D 211/48
Total number of patents in this class: 100
10-year publication summary
|
11
|
11
|
10
|
2
|
6
|
3
|
7
|
5
|
8
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Pfizer Inc. | 3385 |
6 |
| Bristol-myers Squibb Company | 4875 |
4 |
| Cognition Therapeutics, Inc. | 37 |
4 |
| Ono Pharmaceutical Co., Ltd. | 432 |
4 |
| Theravance Biopharma R&D IP, LLC | 516 |
4 |
| Massachusetts Institute of Technology | 9956 |
3 |
| The Broad Institute, Inc. | 1726 |
3 |
| Chronos Therapeutics Limited | 19 |
3 |
| Gilead Sciences, Inc. | 1979 |
3 |
| Incyte Holdings Corporation | 658 |
3 |
| Teijin Pharma Limited | 254 |
3 |
| Grey Wolf Therapeutics Limited | 16 |
3 |
| Suzhou Abogen Biosciences Co., Ltd. | 68 |
3 |
| AstraZeneca AB | 2963 |
2 |
| Agios Pharmaceuticals, Inc | 215 |
2 |
| DIC Corporation | 3698 |
2 |
| Lek Pharmaceuticals d.d. | 210 |
2 |
| Nagoya Industrial Science Research Institute | 27 |
2 |
| NHWA Pharma. Corporation | 52 |
2 |
| Nippon Zoki Pharmaceutical Co., Ltd. | 149 |
2 |
| Other owners | 40 |